Status:
COMPLETED
The Registry of Oncology Outcomes Associated with Testing and Treatment
Lead Sponsor:
Taproot Health
Conditions:
Adenocarcinoma
Adenocystic Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study is to collect and validate regulatory-grade real-world data (RWD) in oncology using the novel, Master Observational Trial construct. This data can be then used in real-world evidence (RWE) ...
Detailed Description
This is a master observational trial (MOT). Anyone who has been diagnosed with advanced cancer is eligible as long as they are a candidate for treatment. Each patient will receive testing and treatmen...
Eligibility Criteria
Inclusion
- Patient or representative provides written informed consent
- Patient is diagnosed with advanced malignancy
- Patient is willing to be treated for this malignancy according to a plan determine by them and their physician
- patient will be willing to have regular follow up visits as part of their standard of care
Exclusion
- patient is not a candidate or does not desire any treatment for their disease
Key Trial Info
Start Date :
May 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT04028479
Start Date
May 5 2021
End Date
October 31 2024
Last Update
December 18 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Teton Cancer Institute
Idaho Falls, Idaho, United States, 83404
2
Oncology and Hematology of South Texas
Laredo, Texas, United States, 78041